American Journal of Cardiology
Volume 100, Issue 5 , Pages 747-752 , 1 September 2007

Safety and Efficacy of Atorvastatin-Induced Very Low-Density Lipoprotein Cholesterol Levels in Patients With Coronary Heart Disease (a Post Hoc Analysis of the Treating to New Targets [TNT] Study)†

  • John C. LaRosa, MD

      Affiliations

    • State University of New York Health Science Center, New York, New York
    • Corresponding Author InformationCorresponding author: Tel: 718-270-2611; fax: 718-270-4732.
    • ,
  • Scott M. Grundy, MD, PhD

      Affiliations

    • University of Texas Southwestern Medical Center, Dallas, Texas
    • ,
  • John J.P. Kastelein, MD

      Affiliations

    • Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • John B. Kostis, MD

      Affiliations

    • University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey
    • ,
  • Heiner Greten, MD

      Affiliations

    • Hanseatisches Herzzentrum Hamburg, Hamburg, Germany.
    • ,
  • Treating to New Targets (TNT) Steering Committee and Investigators

Received 10 January 2007 ,Revised 28 March 2007 ,Accepted 28 March 2007.

 The Treating to New Targets study was funded by Pfizer, Inc., New York, New York.

PII: S0002-9149(07)00990-3

doi: 10.1016/j.amjcard.2007.03.102

American Journal of Cardiology
Volume 100, Issue 5 , Pages 747-752 , 1 September 2007

Article Tools

* Image Usage & Resolution